DK0751988T3 - Højeffektiv fremstilling og isolering af virale partikler - Google Patents
Højeffektiv fremstilling og isolering af virale partiklerInfo
- Publication number
- DK0751988T3 DK0751988T3 DK95914170T DK95914170T DK0751988T3 DK 0751988 T3 DK0751988 T3 DK 0751988T3 DK 95914170 T DK95914170 T DK 95914170T DK 95914170 T DK95914170 T DK 95914170T DK 0751988 T3 DK0751988 T3 DK 0751988T3
- Authority
- DK
- Denmark
- Prior art keywords
- exchange resin
- cells
- viral particles
- isolation
- retroviral particles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21583394A | 1994-03-22 | 1994-03-22 | |
PCT/US1995/003668 WO1995025789A1 (en) | 1994-03-22 | 1995-03-22 | Highly efficient production and isolation of viral particles |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0751988T3 true DK0751988T3 (da) | 2000-06-26 |
Family
ID=22804586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95914170T DK0751988T3 (da) | 1994-03-22 | 1995-03-22 | Højeffektiv fremstilling og isolering af virale partikler |
Country Status (12)
Country | Link |
---|---|
US (2) | US5661023A (pt) |
EP (1) | EP0751988B1 (pt) |
JP (1) | JP3313117B2 (pt) |
AT (1) | ATE189697T1 (pt) |
AU (1) | AU2127395A (pt) |
CA (1) | CA2186034C (pt) |
DE (1) | DE69515028T2 (pt) |
DK (1) | DK0751988T3 (pt) |
ES (1) | ES2141929T3 (pt) |
GR (1) | GR3033268T3 (pt) |
PT (1) | PT751988E (pt) |
WO (1) | WO1995025789A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE189697T1 (de) * | 1994-03-22 | 2000-02-15 | Immune Response Corp Inc | Die hocheffiziente herstellung und isolierung von viruspartikeln |
SK181098A3 (en) * | 1996-07-01 | 1999-07-12 | Rhone Poulenc Rorer Sa | Method for producing recombinant adenovirus |
FR2750433B1 (fr) * | 1996-07-01 | 1998-08-14 | Rhone Poulenc Rorer Sa | Procede de production d'adenovirus recombinants |
NZ335947A (en) | 1996-11-20 | 2000-12-22 | Introgen Therapeutics Inc | A method for the production and purification of adenoviral vectors |
US7732129B1 (en) | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
CA2995542A1 (en) * | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
DE69919981T2 (de) * | 1998-01-12 | 2005-09-15 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food, Ottawa | Verfahren für die isolierung, rückgewinnung und reinigung von nicht-polaren extrakten |
US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
DE10010342A1 (de) * | 2000-03-06 | 2001-09-20 | Merck Patent Gmbh | Verfahren zur Abreicherung von Endotoxinen |
SE0001132D0 (sv) * | 2000-03-29 | 2000-03-29 | Cavidi Tech Ab | Method of concentrating and recovering a viral enzyme activity from biological samples |
US20040101964A1 (en) * | 2000-05-10 | 2004-05-27 | Shigemitsu Takashima | Method of preparing virus vector |
AU2002236517A1 (en) | 2000-11-29 | 2002-06-11 | University Of Southern California | Targetet retoviral vectors for cancer immunotherapy |
EP1377273B1 (de) * | 2001-02-11 | 2009-03-18 | Aquanova Ag | Verfahren zur herstellung eines isoflavon-konzentrats |
DE10137515A1 (de) * | 2001-07-26 | 2003-02-13 | Diagnostikforschung Inst | Verfahren zur Herstellung pharmazeutischer Zubereitungen |
US20030031626A1 (en) * | 2001-07-26 | 2003-02-13 | Thomas Rheinlander | Process for the production of pharmaceutical preparations |
US20070178066A1 (en) * | 2003-04-21 | 2007-08-02 | Hall Frederick L | Pathotropic targeted gene delivery system for cancer and other disorders |
EP1619951B1 (en) * | 2003-04-21 | 2011-06-22 | Epeius Biotechnologies Corporation | Methods and compositions for treating disorders |
US20090123428A1 (en) * | 2003-04-21 | 2009-05-14 | Hall Frederick L | Pathotropic targeted gene delivery system for cancer and other disorders |
AU2005305347A1 (en) | 2004-11-03 | 2006-05-18 | Introgen Therapeutics Inc. | Method of producing and purifying of adenoviral vectors |
PL2307551T3 (pl) | 2008-06-18 | 2017-07-31 | Oxford Biomedica (Uk) Limited | Oczyszczanie wektorów retrowirusowych |
BR112012026095A2 (pt) | 2010-04-14 | 2015-09-15 | Emd Millipore Corp | métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos. |
DE102010046817A1 (de) * | 2010-09-28 | 2012-03-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium |
EP3219313B1 (en) | 2011-04-18 | 2020-10-28 | National Center of Neurology and Psychiatry | Drug delivery particle and method for producing the same |
JP6469574B2 (ja) | 2012-09-17 | 2019-02-13 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | 官能化粒状保持体ならびにその製造法及び使用法 |
AU2013330344B2 (en) | 2012-09-17 | 2018-07-05 | W. R. Grace & Co.-Conn. | Chromatography media and devices |
US11229896B2 (en) | 2014-01-16 | 2022-01-25 | W.R. Grace & Co.—Conn. | Affinity chromatography media and chromatography devices |
WO2015168383A1 (en) | 2014-05-02 | 2015-11-05 | W. R. Grace & Co.-Conn. | Functionalized support material and methods of making and using functionalized support material |
BR112017026193B1 (pt) | 2015-06-05 | 2021-09-14 | W.R. Grace & Co-Conn | Adsorventes, método de produção dos adsorventes e uso dos adsorventes |
CN111417713B (zh) * | 2017-11-22 | 2024-04-26 | 康宁股份有限公司 | 灌注生物反应器系统及灌注细胞培养方法 |
US11028124B2 (en) | 2018-05-07 | 2021-06-08 | Repligen Corporation | Methods, devices and systems for 3-stage filtration |
WO2020214676A1 (en) * | 2019-04-15 | 2020-10-22 | Children's Hospital Medical Center | Viral vector manufacturing methods |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3509070A (en) * | 1968-06-13 | 1970-04-28 | American Home Prod | Adsorbent for chromatographic purification of virus |
US3655509A (en) * | 1969-05-29 | 1972-04-11 | Monsanto Co | Process for the separation of virus from non-viral proteins |
US3925152A (en) * | 1971-06-18 | 1975-12-09 | Exploaterings Ab Tbf | Virus separation |
US4647773A (en) * | 1984-04-23 | 1987-03-03 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS |
JPS6147185A (ja) * | 1984-08-09 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスの精製方法 |
JPS6151571A (ja) * | 1984-08-21 | 1986-03-14 | Nippon Seibutsu Kagaku Kenkyusho | オ−エスキ−病診断用抗原の単離・精製法 |
UA27716C2 (uk) * | 1987-06-10 | 2000-10-16 | Дзе Імюн Респонс Корпорейшн Інк. | Імуноген для лікування індивідуума, зараженого ретровірусом віл |
NZ225583A (en) * | 1987-08-06 | 1991-07-26 | Merck & Co Inc | Process for purifying hepatitis a virions (hav) |
JP2624894B2 (ja) * | 1990-03-09 | 1997-06-25 | カイロン コーポレイション | 天然のコンホメーションを保持している精製gp120組成物 |
FR2661834B1 (fr) * | 1990-05-09 | 1995-01-27 | Merieux Inst | Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus. |
EP0564539A4 (en) * | 1990-12-13 | 1996-03-06 | Us Commerce | Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
ATE189697T1 (de) * | 1994-03-22 | 2000-02-15 | Immune Response Corp Inc | Die hocheffiziente herstellung und isolierung von viruspartikeln |
JPH08195877A (ja) * | 1995-01-18 | 1996-07-30 | Canon Inc | イメージセンサと画像処理回路 |
-
1995
- 1995-03-22 AT AT95914170T patent/ATE189697T1/de not_active IP Right Cessation
- 1995-03-22 WO PCT/US1995/003668 patent/WO1995025789A1/en active IP Right Grant
- 1995-03-22 CA CA002186034A patent/CA2186034C/en not_active Expired - Fee Related
- 1995-03-22 EP EP95914170A patent/EP0751988B1/en not_active Expired - Lifetime
- 1995-03-22 DE DE69515028T patent/DE69515028T2/de not_active Expired - Fee Related
- 1995-03-22 DK DK95914170T patent/DK0751988T3/da active
- 1995-03-22 AU AU21273/95A patent/AU2127395A/en not_active Abandoned
- 1995-03-22 ES ES95914170T patent/ES2141929T3/es not_active Expired - Lifetime
- 1995-03-22 JP JP52482495A patent/JP3313117B2/ja not_active Expired - Fee Related
- 1995-03-22 PT PT95914170T patent/PT751988E/pt unknown
-
1996
- 1996-03-11 US US08/613,920 patent/US5661023A/en not_active Expired - Fee Related
-
1997
- 1997-04-15 US US08/842,702 patent/US6080571A/en not_active Expired - Fee Related
-
2000
- 2000-04-19 GR GR20000400951T patent/GR3033268T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5661023A (en) | 1997-08-26 |
JPH10500286A (ja) | 1998-01-13 |
US6080571A (en) | 2000-06-27 |
DE69515028T2 (de) | 2000-06-29 |
EP0751988A4 (en) | 1997-11-12 |
CA2186034A1 (en) | 1995-09-28 |
EP0751988B1 (en) | 2000-02-09 |
ATE189697T1 (de) | 2000-02-15 |
GR3033268T3 (en) | 2000-09-29 |
PT751988E (pt) | 2000-05-31 |
DE69515028D1 (de) | 2000-03-16 |
WO1995025789A1 (en) | 1995-09-28 |
ES2141929T3 (es) | 2000-04-01 |
EP0751988A1 (en) | 1997-01-08 |
AU2127395A (en) | 1995-10-09 |
JP3313117B2 (ja) | 2002-08-12 |
CA2186034C (en) | 2002-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0751988T3 (da) | Højeffektiv fremstilling og isolering af virale partikler | |
EP1394259A3 (en) | Recombinant infectious non-segmented negative strand RNA virus | |
AU7007491A (en) | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses | |
MX9701183A (es) | Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones. | |
EP0923308A4 (pt) | ||
IT8020489A0 (it) | Procedimento per la formazione di elettrodi sulle superficie di membrane semipermeabili e sistemi elettrodo-membrana cosi' prodotti. | |
DK0871482T3 (da) | Rekombinante vesiculovirus og deres anvendelser | |
HK1018287A1 (en) | (-)-strand rna virus vector having autonomously replicating activity | |
TR199901840T2 (xx) | DNA'nın cross-flow-filtrasyonu ile temizlenmesi. | |
DK0923592T3 (da) | Fremgangsmåder til rensning af nukleinsyrer | |
ATE333501T1 (de) | Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) | |
DE3271691D1 (en) | Semipermeable membranes of modified polystyrene, process for their manufacture and their use | |
DK577783A (da) | Vektor for udtrykkelse af et dna-segment i gaer | |
NO931093L (no) | Fremgangsmaate for fremstilling av rensede glykolipider ved membrana dskillelsesfremgangsmaaten | |
PT88178A (pt) | Metodo para a purificacao de virus da hepatite a | |
DE59610319D1 (de) | Entfernen von Viren durch Ultrafiltration aus Proteinlösungen | |
AU6827798A (en) | Filtration method for separating viruses | |
DK0514421T4 (da) | Fremgangsmåde til virusreduktion i opløsninger og bestemmelse af virusreduktionsraten | |
DE69324645D1 (de) | Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen | |
DK78990A (da) | Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza | |
DE69103798D1 (de) | Katalysatorsystem und -verfahren zur selektiven Herstellung von Isoprenyl-Alkylethern aus Isopren. | |
FI98466B (fi) | FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi | |
NO164023C (no) | 2-azetidinyl-eddiksyre, middel inneholdende samme og anvendelse av 2-azetidinyl-eddiksyre ved sterilisering av en plantes stoevknapper. | |
CA2154854A1 (en) | Immortalized lymphocytes for production of viral-free proteins | |
AU2860384A (en) | Cloning vector,method of constructing such,and method of concentrating and purifying product proteins produced by the cloning vector |